0000914475-13-000008.txt : 20130114
0000914475-13-000008.hdr.sgml : 20130114
20130114171656
ACCESSION NUMBER: 0000914475-13-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130110
FILED AS OF DATE: 20130114
DATE AS OF CHANGE: 20130114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OBrien Christopher Flint
CENTRAL INDEX KEY: 0001343124
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 13528546
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-01-10
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001343124
OBrien Christopher Flint
NEUROCRINE BIOSCIENCES, INC.
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
Stock Option
8.65
2013-01-10
4
A
0
86000
8.65
A
2013-02-10
2023-01-10
Common Stock
86000
86000
D
Restricted Stock Unit
2013-01-10
4
A
0
14000
0
A
Common Stock
14000
14000
D
Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on February 10, 2013, an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.
Each restricted stock unit represents a contingent right to receive one share of Neurocrine Common Stock.
The restricted stock units will vest annually at 1/4 of the units vesting on January 10, 2014, January 10, 2015, January 10, 2016 and January 10, 2017, respectively.
Margaret E. Valeur-Jensen, By Power of Attorney
2013-01-14